Mon, Jan 26, 2015, 11:02 AM EST - U.S. Markets close in 4 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

  • jagan1961 jagan1961 Apr 27, 2013 7:59 PM Flag

    For all newbies, pumpers & bashers!

    I've been here for almost 3 years, had a huge stake and sold majority of them prior to the approval. Finally I sold out during Sep-Oct or so for 14-15 and got out. The issue facing Affy have always been giant AMGN irrespective of the drugs issues (of late and the subsequent recalls).

    Takeda on its own can match AMGN one on one.

    Currently the stock is at 90-95 cents. I wrote earlier the potential if and when FDA approves, The potential payout is:

    $5 - Milestone payment
    Potential upto 300 MLN (2 BLN sales @15% Royalty- no expenses) = $8 per year for the next 15 years

    Since AFFY does not have any operations, you can say probably max of 1-2 MLN expenses.

    They have close to 500 MLN NOL, which can shield them forever.

    Anyone buying AFFY is buying a fully Paid CALL OPTION for the above deal and collect your payout for the entire lifetime.

    This is the best deal you could ever get. IMHO the BOD has done everything right under the circumstances, after watching independent AFFY under ORWIN fumble in every respect, no fault of him, size of AMGN the core competitor is NO SMALL.

    Takeda is the new owner and responsible party to do what is good for them. For them it is a blockbuster drug and they will have to make it to work, they will do everything at their disposal to straighten this out.

    I bought on worked for 99.98% of the population and only during the problem occurred the first day. Once worked for a day, it never had an issue. The problems seems very easy to fix, of course I'm not a scientist or a nephrologist, however I've been here for long and read lots of stuff with this anemia by spending precious time.

    With almost 600 MLN spent already and having the control over the drug, it is Takeda who needs to get it straightened out. Takeda has been dealing with 100's of companies worldwide in terms of licensing.
    If you have shorted at high 20's made an amazing stuff. @90 cents, shorties will loose a ton on any small positive development, it is not worth the risk, JMHO

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AFFY
0.141-0.0005(-0.35%)10:22 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.